Morgan Stanley Beyond Air, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Beyond Air, Inc. stock. As of the latest transaction made, Morgan Stanley holds 5,718 shares of XAIR stock, worth $18,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,718

Previous 5,618 1.78%

Holding current value

$18,068

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$0.16 - $0.25 $16 - $25	100 Added 1.78%	5,718 $0
Q1 2025 May 15, 2025	SELL	$0.24 - $0.45 $48 - $90	-200 Reduced 3.44%	5,618 $1,000
Q4 2024 Feb 14, 2025	SELL	$0.3 - $0.67 $10,742 - $23,991	-35,808 Reduced 86.02%	5,818 $2,000
Q3 2024 May 14, 2025	SELL	$0.36 - $0.64 $38,622 - $68,662	-107,285 Reduced 72.05%	41,626 $16,000
Q3 2024 Nov 14, 2024	SELL	$0.36 - $0.64 $38,622 - $68,662	-107,285 Reduced 72.05%	41,626 $16,000
Q2 2024 May 14, 2025	BUY	$0.54 - $1.67 $77,270 - $238,965	143,093 Added 2459.49%	148,911 $80,000
Q2 2024 Oct 17, 2024	SELL	$0.54 - $1.67 $76,471 - $236,495	-141,614 Reduced 48.74%	148,911 $80,000
Q2 2024 Aug 14, 2024	SELL	$0.54 - $1.67 $76,471 - $236,495	-141,614 Reduced 48.74%	148,911 $80,000
Q1 2024 Oct 17, 2024	BUY	$1.3 - $2.15 $184,098 - $304,470	141,614 Added 95.1%	290,525 $505,000
Q1 2024 Aug 16, 2024	SELL	$1.3 - $2.15 $69,771 - $115,390	-53,670 Reduced 15.59%	290,525 $505,000
Q1 2024 May 15, 2024	SELL	$1.3 - $2.15 $69,771 - $115,390	-53,670 Reduced 15.59%	290,525 $505,000
Q4 2023 Aug 16, 2024	BUY	$1.4 - $2.46 $273,397 - $480,398	195,284 Added 131.14%	344,195 $674,000
Q4 2023 Feb 13, 2024	BUY	$1.4 - $2.46 $197,699 - $347,386	141,214 Added 69.57%	344,195 $674,000
Q3 2023 Nov 15, 2023	BUY	$2.31 - $4.18 $219,346 - $396,911	94,955 Added 87.9%	202,981 $468,000
Q2 2023 Aug 14, 2023	SELL	$4.26 - $6.92 $44,627 - $72,493	-10,476 Reduced 8.84%	108,026 $460,000
Q1 2023 May 15, 2023	BUY	$5.65 - $7.56 $124,723 - $166,887	22,075 Added 22.89%	118,502 $799,000
Q4 2022 Feb 14, 2023	BUY	$5.47 - $7.9 $99,893 - $144,269	18,262 Added 23.36%	96,427 $625,000
Q3 2022 Nov 14, 2022	BUY	$7.42 - $11.39 $28,255 - $43,373	3,808 Added 5.12%	78,165 $582,000
Q2 2022 Oct 27, 2022	SELL	$4.96 - $7.83 $90,455 - $142,795	-18,237 Reduced 19.7%	74,357 $498,000
Q2 2022 Aug 15, 2022	SELL	$4.96 - $7.83 $90,455 - $142,795	-18,237 Reduced 19.7%	74,357 $498,000
Q1 2022 Oct 27, 2022	BUY	$6.33 - $9.53 $115,440 - $173,798	18,237 Added 24.53%	92,594 $618,000
Q1 2022 May 13, 2022	SELL	$6.33 - $9.53 $15,584 - $23,462	-2,462 Reduced 2.59%	92,594 $618,000
Q4 2021 Feb 14, 2022	BUY	$8.44 - $15.61 $150,805 - $278,919	17,868 Added 23.15%	95,056 $898,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $12.54 $455,409 - $967,937	77,188 New	77,188 $859,000

Others Institutions Holding XAIR

# of Institutions

Shares Held

11.3M

Call Options Held

49.6K

Put Options Held

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $94.4M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account